A Systematic Review Supporting the Endocrine Society Clinical Practice Guidelines on Vitamin D

  • Vishal Paresh Shah
  • , Tarek Nayfeh
  • , Yahya Alsawaf
  • , Samer Saadi
  • , Magdoleen Farah
  • , Ye Zhu
  • , Mohammed Firwana
  • , Mohamed Seisa
  • , Zhen Wang
  • , Robert Scragg
  • , Mairead E. Kiely
  • , Paul Lips
  • , Deborah M. Mitchell
  • , Marie B. Demay
  • , Anastassios G. Pittas
  • , Mohammad Hassan Murad

Research output: Contribution to journalReview articlepeer-review

Abstract

Context: Low vitamin D status is common and is associated with various common medical conditions. Objective: To support the development of the Endocrine Society’s Clinical Practice Guideline on Vitamin D for the Prevention of Disease. Methods: We searched multiple databases for studies that addressed 14 clinical questions prioritized by the guideline panel. Of the 14 questions, 10 clinical questions assessed the effect of vitamin D vs no vitamin D in the general population throughout the lifespan, during pregnancy, and in adults with prediabetes; 1 question assessed dosing; and 3 questions addressed screening with serum 25-hydroxyvitamin D (25[OH]D). The Grading of Recommendations Assessment, Development and Evaluation approach was used to assess certainty of evidence. Results: Electronic searches yielded 37 007 citations, from which we included 151 studies. In children and adolescents, low-certainty evidence suggested reduction in respiratory tract infections with empiric vitamin D. There was no significant effect on select outcomes in healthy adults aged 19 to 74 years with variable certainty of evidence. There was a very small reduction in mortality among adults older than 75 years with high certainty of evidence. In pregnant women, low-certainty evidence suggested possible benefit on various maternal, fetal, and neonatal outcomes. In adults with prediabetes, moderate certainty of evidence suggested reduction in the rate of progression to diabetes. Administration of high-dose intermittent vitamin D may increase falls, compared to lower-dose daily dosing. We did not identify trials on the benefits and harms of screening with serum 25(OH)D. Conclusion: The evidence summarized in this systematic review addresses the benefits and harms of vitamin D for the prevention of disease. The guideline panel considered additional information about individuals’ and providers’ values and preferences and other important decisional and contextual factors to develop clinical recommendations.

Original languageEnglish
Pages (from-to)1961-1974
Number of pages14
JournalJournal of Clinical Endocrinology and Metabolism
Volume109
Issue number8
DOIs
Publication statusPublished - 1 Aug 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 25(OH)D
  • Endocrine Society
  • guidelines
  • systematic reviews
  • vitamin D

Fingerprint

Dive into the research topics of 'A Systematic Review Supporting the Endocrine Society Clinical Practice Guidelines on Vitamin D'. Together they form a unique fingerprint.

Cite this